At the most delicate threshold of assisted reproduction—the moment an embryo is placed into the womb—medicine has long relied on ritual as much as reason. A new Cochrane review of 11 studies reveals that three widely practiced IVF embryo transfer preparation techniques carry no reliable evidence of improving pregnancy outcomes, exposing a quiet gap between clinical habit and scientific proof. The finding is less an indictment of individual clinicians than a reflection of how tradition, in the absence of rigorous inquiry, becomes its own kind of authority. What remains is a call not for alarm,
Cochrane review finds IVF prep techniques lack proven benefit, calls for better trials
Tradition is driving practice rather than the evidence
Why hasn't this been settled already? IVF has been around for decades.
Because embryo transfer is hard to study. You can't easily randomize women into different techniques when they're putting their one viable embryo at risk. And most research attention moved toward embryo quality, which matters more for outcomes.
So clinics are just doing whatever they've always done?
Essentially, yes. Tradition and local protocol drive practice more than evidence does. A clinic that's always used full bladder preparation keeps using it, not because it's proven to work, but because that's how they do things.
Is there actual harm from these techniques?
Not major harm, no. A full bladder is uncomfortable. Cervical mucus removal done carelessly might cause minor bleeding. But the real problem isn't safety—it's that women may be experiencing discomfort for no proven benefit.
Why focus on resource-limited settings for future trials?
Because these procedures are cheap and simple to change. In places with fewer resources, getting the basics right could matter more than advanced technical tweaks. And if a simple standardized protocol works, it could help more people.
What would a good trial actually look like?
Larger, more rigorous studies with better methodology. But you'd also need women willing to participate, which is the hard part—asking someone to randomize their embryo transfer when the outcome is so important.
The Pulse
- Only one in three embryo transfers results in pregnancy, yet the preparation techniques meant to improve those odds have never been proven to work.
- Full bladder protocols, cervical mucus removal, and afterloading are performed routinely across fertility clinics worldwide—driven by local custom and clinician habit rather than evidence.
- Women may endure real physical discomfort, including the sustained pressure of a full bladder, for interventions whose benefit remains scientifically undemonstrated.
- Sixteen years of research have failed to answer a foundational question about IVF technique, with all existing studies rated low or very low in evidentiary certainty.
- Researchers are now pressing for large-scale, rigorous trials—especially in resource-limited settings where simple procedural standardization could carry the greatest impact.
At the most delicate threshold of assisted reproduction—the moment an embryo is placed into the womb—medicine has long relied on ritual as much as reason. A new Cochrane review of 11 studies reveals that three widely practiced IVF embryo transfer preparation techniques carry no reliable evidence of improving pregnancy outcomes, exposing a quiet gap between clinical habit and scientific proof. The finding is less an indictment of individual clinicians than a reflection of how tradition, in the absence of rigorous inquiry, becomes its own kind of authority. What remains is a call not for alarm, but for the honest, careful work of knowing.
Embryo transfer is the final and most fragile step in IVF, with only roughly one in three transfers resulting in pregnancy. To improve those odds, fertility clinics have long employed a range of preparation techniques—but a new Cochrane review of 11 studies involving more than 2,500 women has found that none of the three most common methods carry reliable scientific support. Full bladder protocols, cervical mucus removal, and a guidance technique called afterloading are all widely used, yet the trials examining them were small, methodologically weak, and rated at low or very low certainty.
What makes the finding particularly striking is how deeply embedded these practices have become. Clinics vary widely in what they do, and that variation reflects not evidence-based medicine but tradition—what a clinic has always done, shaped by local convention and clinician preference. Dr. Ryosuke Akino of Kato Ladies Clinic noted plainly that custom, not research, is steering practice.
The techniques are generally considered safe, though a full bladder can be genuinely uncomfortable, and careless mucus removal may cause minor bleeding. The real concern is not harm but futility—whether these interventions help at all. That question, despite years of study, remains unanswered.
Part of the problem is structural. IVF research has concentrated on embryo quality and genetics, which bear far more heavily on success rates than transfer technique does. Transfer itself depends heavily on individual clinician skill, making it difficult to standardize and study rigorously. Women are often reluctant to enroll their embryos in randomized trials, and all existing studies were conducted in high-income countries.
Dr. Noyuri Yamaji of Showa Medical University expressed frustration that sixteen years of inquiry have not resolved a basic procedural question. Researchers argue the case for better trials is especially urgent in resource-limited settings, where low-cost procedural standardization could matter most. The path forward is not complicated in concept—only in commitment: larger, more rigorous studies, built around the question of what actually works.
Embryo transfer is the final step in in vitro fertilization, and it is also the most fragile. Only about one in three transfers results in pregnancy. To improve those odds, fertility clinics around the world have adopted various preparation techniques—small interventions meant to make the transfer easier and more likely to succeed. The problem is that no one has proven any of them actually work.
A new Cochrane review examined 11 studies involving 2,524 women to test three common preparation methods: having women arrive with a full bladder to straighten the angle of the uterus and cervix, removing cervical mucus before the procedure, and a technique called afterloading, which guides the embryo through the cervix. The researchers found that none of these practices had reliable evidence supporting them. The trials were small, methodologically weak, and the certainty of the evidence was rated low or very low. In other words, after analyzing the best available research, the reviewers could not recommend any of these techniques over standard care.
What makes this finding striking is how entrenched these practices have become. Fertility clinics vary widely in what they do—some routinely use bladder-filling protocols, others skip them entirely. The variation reflects not evidence-based medicine but rather local tradition, clinician preference, and historical convention. Dr. Ryosuke Akino, an obstetrician-gynecologist at Kato Ladies Clinic, put it plainly: tradition is driving practice rather than the evidence. Current protocols often reflect what a clinic has always done, not what research has shown to work.
The techniques themselves are generally considered safe. A full bladder can be uncomfortable, and cervical mucus removal, if done carelessly, might cause minor bleeding that affects a woman's experience. But major complications are rare. The real issue is not safety but effectiveness—and on that question, the evidence remains silent. Dr. James Brown, from Women's Health and Research Institute Australia, noted that while these techniques are considered safe, it is still important to test whether they actually improve outcomes.
The reason this gap exists is partly structural. Most advances in IVF over recent decades have focused on embryo quality and genetic factors, which have a much larger bearing on success rates than transfer technique. Embryo transfer is also highly dependent on the skill and judgment of the person performing it, making it difficult to standardize and even harder to study in rigorous trials. Women are often reluctant to enroll their valuable embryos in randomized experiments. And the studies that have been done were all conducted in high-income countries, so the findings may not apply elsewhere.
Dr. Noyuri Yamaji from Showa Medical University in Japan expressed frustration with the slow pace of progress. Sixteen years of research have still not answered a basic question about IVF technique. This is a critical step in the process, and small changes could potentially make a massive difference—but without better, larger trials, no one will know. The researchers argue that the case for investing in rigorous trials is especially strong in resource-limited settings, where simple procedural standardization might matter more than advanced technical modifications and where the low cost of these interventions makes them worth studying carefully.
What emerges from this review is a portrait of a field caught between tradition and uncertainty. Women undergoing IVF may experience unnecessary discomfort from full bladder procedures or other interventions that have never been proven to help. Clinics continue to use techniques because that is what they have always done. And the research infrastructure needed to answer a straightforward question—does this actually work?—has not been built. The path forward is clear: better trials, conducted with rigor and scale, particularly in settings where the stakes of getting it right are highest.
Notable Quotes
Tradition is driving practice rather than the evidence. Current practices often reflect local protocols, clinician preference, and historical convention rather than strong, high-quality evidence.— Dr. Ryosuke Akino, obstetrician-gynecologist, Kato Ladies Clinic
Sixteen years of research still haven't answered a basic IVF technique question. This is a critical step in the IVF process and these small changes and techniques have the possibility to make a massive difference, but we won't know more until more robust, better-quality trials are conducted.— Dr. Noyuri Yamaji, Showa Medical University, Japan